103 related articles for article (PubMed ID: 5043228)
1. Phase II study of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the treatment of bronchogenic carcinoma.
Olshin S; Siddiqui S; Firat D
Cancer Chemother Rep; 1972 Apr; 56(2):259-61. PubMed ID: 5043228
[No Abstract] [Full Text] [Related]
2. Combined therapy with cytosine arabinoside (NSC-63878) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for advanced solid tumors.
Kinne DW; Humphrey EW
Cancer Chemother Rep; 1972 Feb; 56(1):53-9. PubMed ID: 5030809
[No Abstract] [Full Text] [Related]
3. Evaluation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the management of patients with advanced breast cancer.
Ahmann DL; Hahn RG; Bisel HF
Cancer Chemother Rep; 1972 Feb; 56(1):93-4. PubMed ID: 5030810
[No Abstract] [Full Text] [Related]
4. 5-Fluorouracil (5-Fu; NSC-19893), 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388), vincristine (NSC-67574), and 1,3-bis(2-chloroethyl)-2-nitrosourea (BCNU; NSC-409962) given concomitantly in the treatment of solid tumors in man.
van Eden EB; Falkson G; van Dyk JJ; van der Merwe AM; Falkson HC
Cancer Chemother Rep; 1972 Feb; 56(1):107-47. PubMed ID: 5030803
[No Abstract] [Full Text] [Related]
5. Treatment of Hodgkin's disease and other cancers with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
Marsh JC; DeConti RC; Hubbard SP
Cancer Chemother Rep; 1971 Dec; 55(5):599-606. PubMed ID: 4334161
[No Abstract] [Full Text] [Related]
6. Treatment of advanced Hodgkin's disease with (1,3 bis (2-chloroethyl)-1-nitrosourea) BCNU.
Young RC; DeVita VT; Serpick AA; Canellos GP
N Engl J Med; 1971 Aug; 285(9):475-9. PubMed ID: 5558887
[No Abstract] [Full Text] [Related]
7. BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea; NSC-409962) in the treatment of malignant brain tumor--a preliminary report.
Walker MD; Hurwitz BS
Cancer Chemother Rep; 1970 Aug; 54(4):263-71. PubMed ID: 4946011
[No Abstract] [Full Text] [Related]
8. Enhancement of the antitumor effect of 1,3-bis(2-chloroethyl)-1-nitrosourea by vitamin A and caffeine.
Cohen MH
J Natl Cancer Inst; 1972 Apr; 48(4):927-32. PubMed ID: 5023690
[No Abstract] [Full Text] [Related]
9. 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given concomitantly with cytosine arabinoside (NSC-63878) in the treatment of cancer.
van Eden EB; Falkson HC; Falkson G
Cancer Chemother Rep; 1970 Oct; 54(5):347-59. PubMed ID: 5514624
[No Abstract] [Full Text] [Related]
10. Evaluation of cyclophosphamide (NSC-26271) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the treatment of patients with inoperable or disseminated lung cancer.
Ahmann DL; Carr DT; Coles DT; Hahn RG
Cancer Chemother Rep; 1972 Jun; 56(3):401-3. PubMed ID: 19051501
[TBL] [Abstract][Full Text] [Related]
11. Nitrosoureas: 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962; BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC-79037; CCNU)--clinical brochure.
Carter SK; Newman JW
Cancer Chemother Rep 3; 1968 Dec; 1(1):115-51. PubMed ID: 4917773
[No Abstract] [Full Text] [Related]
12. Combination chemotherapy of bronchogenic carcinoma with cyclophosphamide (NSC-26271) and BCNU (NSC-409962).
Curtis JE
Cancer Chemother Rep; 1974; 58(6):883-8. PubMed ID: 4614897
[No Abstract] [Full Text] [Related]
13. Treatment of mycosis fungoides with topical nitrosourea compounds.
Zackheim HS
Arch Dermatol; 1972 Aug; 106(2):177-82. PubMed ID: 5048217
[No Abstract] [Full Text] [Related]
14. Phase II study of 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC No. 409962) with amphotericin B in bronchogenic carcinoma.
Presant CA; Hillinger S; Klahr C
Cancer; 1980 Jan; 45(1):6-10. PubMed ID: 6243243
[TBL] [Abstract][Full Text] [Related]
15. 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962) and methotrexate (NSC-740) as combination therapy for advanced mouse leukemia L1210.
Venditti JM; Kline I; Tyrer DD; Goldin A
Cancer Chemother Rep; 1965 Oct; 48():35-9. PubMed ID: 5834736
[No Abstract] [Full Text] [Related]
16. [The organotropy of alkylating activity of dimethylnitrosamine (DMNA) and nitrosomethyl urea (NMH) in vivo].
Krüger FW; Osswald H; Walker G; Schelten E
Z Krebsforsch; 1970; 74(4):434-47. PubMed ID: 4253315
[No Abstract] [Full Text] [Related]
17. Sequential 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and 5-fluorouracil (NSC 19893) therapy of gastrointestinal cancer.
Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
Cancer Res; 1972 Jun; 32(6):1280-2. PubMed ID: 5030827
[No Abstract] [Full Text] [Related]
18. Effect of 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962) and cyclophosphamide (NSC-26271) on nicotinamide adenine dinucleotide glycohydrolase in normal and leukemic mouse tissues.
Tsukagoshi S; Kao MH; Goldin A
Cancer Chemother Rep; 1968 Sep; 52(5):569-78. PubMed ID: 5743704
[No Abstract] [Full Text] [Related]
19. Success and failure in the treatment of solid tumors. 3. "Cure" of metastatic Lewis lung carcinoma with methyl-CCNU (NSC-95442) and surgery-chemotherapy.
Mayo JG; Laster WR; Andrews CM; Schabel FM
Cancer Chemother Rep; 1972 Apr; 56(2):183-95. PubMed ID: 5043226
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]